Personalized medicine in idiopathic pulmonary fibrosis: facts and promises.

@article{Spagnolo2015PersonalizedMI,
  title={Personalized medicine in idiopathic pulmonary fibrosis: facts and promises.},
  author={Paolo Spagnolo and Argyrios Tzouvelekis and Toby M Maher},
  journal={Current opinion in pulmonary medicine},
  year={2015},
  volume={21 5},
  pages={470-8}
}
PURPOSE OF REVIEW In this article, we summarize and discuss the most recent literature on personalized medicine in idiopathic pulmonary fibrosis (IPF), a chronic progressive and almost invariably lethal disease of unknown cause. This review is timely as major advances in our understanding of disease pathobiology and improvements in molecular techniques have recently led to the identification of potential surrogates of diagnosis, prognosis and response to treatment. RECENT FINDINGS The most… CONTINUE READING